Includes a formulation problem for Teva, facility updates from Taro and ADM, and a new excipient screening initiative at the …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

